Single-atom nanozymes: a new platform for central nervous system disease research

Puntos clave

• To explore the role of single-atom nanozymes in researching central nervous system diseases and treating injuries.
• Investigated the properties of single-atom nanozymes in relation to CNS pathology.
• Evaluated the efficacy of nanozymes in mitigating inflammatory damage.
• Analyzed effects on neuronal health using in vitro models.
• Single-atom nanozymes reduced inflammation significantly in affected models.
• Demonstrated improvement in neuronal survival and function after treatment.
• Indicated potential as therapeutic agents targeting CNS injuries.